Ad Stars 2010
The faces and names behind the year's best pharmaceutical advertising.
Pharmaceutical Executive Digital Edition - March 2010
Merck’s Man in Emerging Markets
JWT
DDB New York
All Things to All People?
Is it possible to remain commercially relevant just as a developer and distributor of drugs? Are there equivalent profits in a larger set of commitments?
Sixth Annual Press Audit
Pricing, promotion, and the unfinished story of healthcare reform dominated the news last year.
Stay Ahead of the Technology Curve
In a digital world, vast quantities of data at hand are a powerful asset. Managing that information is key to seizing competitive advantage.
E-Health to Drive Drug Safety
FDA's new Sentinel System is going live, but the signals may be difficult to assess.
Compass Healthcare
Abelson-Taylor
Echo Torre Lazur
The Race Is On
Several leading pharmas may already have a drug for a retrovirus linked to chronic fatigue disease. Has medicine's "problem child" finally earned the industry's respect?
MicroMass
Saatchi & Saatchi
Digitas Health
Palio
Moving Beyond Compliant Social Media
Pharma companies need a clear online policy that addresses employee obligations, monitoring guidelines, and engagement roles.
Managing REMS for the Long Term
Obligations to fund and support costly studies can extend beyond the period of market exclusivity, giving generics competitors an advantage.
EuroRSCG Tonic
DraftFCB
Cadient Interactive
Laughter is the Best Medicine
Here are five pharmaceutical advertisement parodies that will make you howl 'till it hurts.
The New Merck's Move on Emerging Markets
Can the combination with Schering-Plough transform the company from an also-ran to a contender in the big push for market share in the developing world?
